Please login to the form below

Not currently logged in
Email:
Password:

NICE vice-chair to head NHS trust

Mark Taylor, vice-chair of NICE has stepped down and taken up a new role as chair of an NHS Mental Health Trust

Mark Taylor, vice-chair of the National Institute for Health and Clinical Excellence (NICE) has stepped down and taken up a new role as chair of an NHS Mental Health Trust.

Taylor, who has been vice-chair to Sir Michael Rawlins since 2003 has been appointed chairman at Devon Partnership NHS Trust. Commenting on his new role, he said: "My six years at NICE have been among the most satisfying of my professional life. This is not least because the friendliness, dedication and ability of colleagues across the Institute has made working with them an absolute pleasure. NICE is an extraordinary organisation with which I am proud to have been associated and which I know will go from strength to strength."

Sir Michael said: "I congratulate Mark on his new appointment, and would like to thank him on behalf of NICE for his hard work and commitment in helping steer NICE through the many challenges that the Institute has faced. I've valued his support over the last six years, and wish him well in his new post."

30th April 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics